Surgical ablation of atrial fibrillation with a novel bipolar radiofrequency device  by Benussi, Stefano et al.
Benussi et al Surgery for Acquired Cardiovascular DiseaseSurgical ablation of atrial fibrillation with a novel bipolar
radiofrequency device
Stefano Benussi, MD, PhD,a Simona Nascimbene, MD,a Giliola Calori, MD,b Paolo Denti, MD,a Zvi Ziskind, MD,aSamer Kassem, MD,a Giovanni La Canna, MD,a Carlo Pappone, MD, PhD,c and Ottavio Alfieri, MDa
A
CDFrom the Division of Cardiac Surgery,a Ep-
idemiology Unit,b and Division of Arrhyth-
mology,c S Raffaele University Hospital,
Milan, Italy.
Received for publication Sept 29, 2004;
revisions received Jan 10, 2005; accepted
for publication Jan 13, 2005.
Address for reprints: Stefano Benussi, MD,
PhD, Division of Cardiac Surgery, S Raffaele
University Hospital, via Olgettina 60, 20132
Milan, Italy (E-mail: stefano.benussi@
hsr.it).
J Thorac Cardiovasc Surg 2005;130:491-7
0022-5223/$30.00
Copyright © 2005 by The American Asso-
ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2005.01.009Objective: When used for epicardial ablation, unipolar devices do not predictably yield
transmural scars. Bipolar radiofrequency proved highly effective on the animal model,
but clinical experience is still initial. We describe acute electrophysiologic findings and
follow-up results of epicardial ablation with a novel bipolar radiofrequency device.
Methods: A bipolar ablator was used to perform a simplified left atrial lesion set in
90 consecutive patients with atrial fibrillation undergoing open heart surgery. Pacing
thresholds were assessed during surgery to validate 24 pulmonary vein encircling
lines (12 patients). Follow-up was 100% complete.
Results: In 67 of 90 patients (84%), mitral valve disease was the main indication to
surgery. Atrial fibrillation was continuous in 74 patients (82%) and intermittent in
16 patients (18%). Pacing threshold assessment showed a complete conduction
block in 22 of 24 pulmonary vein couples (92%) after a single ablation and in all
patients after doubling of the encircling lines. No complications related to the
ablation procedure were recorded. The sinus rhythm restoration rate was 79% at 3
months, 87% at 6 months, and 89% (17/18 patients) at 1 year. Postablation
organized arrhythmias consisted in right atrial flutter in 2 patients (2%) and left
atrial flutter in 6 patients (7%).
Conclusions: Epicardial ablation with bipolar radiofrequency grants acute transmu-
rality. A simplified lesion set proved highly effective in eliminating atrial fibrillation
at 1-year follow-up. Our data suggest that addition of a lesion to the mitral annulus
is advisable to prevent left atrial flutter.
During the past few years, diverse simplified surgical approaches, all derivedfrom the original Cox maze procedure, have been devised to treat atrialfibrillation (AF).1-5 The principles inspiring such modifications have been
the replacement of incisions with ablations and the reduction of the number of atrial
lines. This has greatly increased accessibility and feasibility of surgery for AF.6
After the first reports at the turn of the millennium,1,7 epicardial ablation has been
adopted by many groups for the concomitant treatment of AF8-10 and as an option
for curing lone AF.8,11
Diverse unipolar ablating systems have been used for epicardial ablation on the
beating heart, with success rates between 77% and 90%.9,10,12 The major limitation
of unipolar devices is that, because of the convective cooling (or heating) exerted by
blood flowing through the atria and due to the composition of the diseased atrial
wall, they do not predictably yield transmural lesions when used epicardially.9,13
Bipolar devices seem a promising way to obviate such problems: The first experi-
mental trials demonstrated that bipolar radiofrequency (RF) ablation can reliably
produce continuous transmural linear scars.14,15 Recent clinical reports document
excellent early rhythm outcomes after bipolar ablation was used to perform a left
atrial lesion set16 or a maze procedure.17,18
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system, describing early electrophysiologic findings and
follow-up results.
Methods
Concomitant AF treatment with bipolar RF was performed in 90
patients between February 2003 and March 2004. Indications for
the ablation procedure were continuous AF (lasting at least 6
months) in 74 patients (82%) and symptomatic intermittent AF
refractory to antiarrhythmic medications or to prior percutaneous
ablation in 16 patients (18%). Seventy-six patients (84%) had
primary mitral valve disease as the main indication to surgery.
Preoperative data are summarized in Table 1.
Informed written consent was signed by each patient before
surgery.
To decrease the risk of intracavitary thrombus formation, a
continuous heparin infusion was administered until 6 hours before
surgery. A preoperative transesophageal echocardiography was
performed in all patients no longer than 24 hours before surgery to
exclude left atrial thrombosis.
All ablations were performed using a novel bipolar RF ablation
system (Cobra Bipolar, Boston Scientific, San Jose, Calif). Two
64-mm–long ablating inserts are mounted on the opposing faces of
the jaws of a stainless steel clamp. Each insert is made of 2 RF
electrodes embedded in a polyester covering. The electrodes have
a thermocouple mounted on each end. Different shapes of the
clamp can be chosen on the basis of the ablation site and the
surgeon’s preference. RF current was delivered for 40 to 45
seconds at 35 to 40 W, with a preset temperature of 90°C.
All the ablations were performed on full cardiopulmonary
bypass at 37°C.
The pattern was basically the same as we described earli-
er3,12; the only exception was the mitral line, which we decided
TABLE 1. Preoperative data
Patients 90s
Male/female 43/47
Age at surgery (y) 64 (55-69)
NYHA I (patients) 7 (8%)
NYHA II (patients) 47 (52%)
NYHA III (patients) 35 (39%)
NYHA IV (patients) 1 (1%)
Ejection fraction (%) 60 (54-60)
Ejection fraction  40% (patients) 11 (12%)
Left atrial diameter (mm) 54 (49-59)
Intermittent AF (patients) 16 (18%)
Continuous AF (patients) 74 (82%)
Duration of AF (mo) 15 (9-49)
Permanent pacemaker (patients) 2 (2%)
Systolic pulmonary artery pressure (mm Hg) 48 (40-55)
Left ventricular telediastolic pressure (mm) 53 (49-60)
Left ventricular telediastolic volume (mL) 101 (76-137)
NYHA, New York Heart Association functional class; AF, atrial fibrillation.
Values are expressed as number and (percentage) for discreet variables
and as number (25th, 75th percentiles) for continuous variables.to omit when using bipolar RF because of concern about injur-
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groove.
After dissection of pericardial reflections, the bipolar device
was clamped around the atrial cuff containing the inflow of the
right pulmonary veins (Figure 1). RF energy was deployed
yielding an encircling lesion. The heart was lifted, the Marshall
fold was interrupted, and a similar encircling lesion was per-
formed on the left pulmonary vein cuff (Figure 2). When
intraoperative conduction block validation was not performed,
the pulmonary vein lesions were always doubled. The append-
age was ablated at its base, away from the A-V groove to not
harm a major coronary artery, and connected to the left encir-
cling by means of an additional ablation with the tip of the
clamp pinching the left encircling line and the base ending in
the body of the left appendage. The line connecting the 2
encirclings was usually performed through a left atriotomy
(Figure 3). One jaw of the clamp was inserted in the left atrium
with the tip in the upper left pulmonary vein or in the append-
age, while the other jaw was outside, in the transverse sinus of
pericardium. Figure 3 depicts the final set of lines. After the
ablations, the appendage was sutured, generally from the inside.
Postoperative Management and Follow-up
Amiodarone was the first-choice antiarrhythmic drug for postop-
erative prophylaxis. In the presence of contraindications to amio-
Figure 1. Encircling ablation with the bipolar radiofrequency (RF)
clamp around the ostia of the right pulmonary veins.darone, sotalol or other medications were given as appropriate.
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Standard 12-lead electrocardiograph, Holter, and transthoracic
echocardiography monitoring were performed 1, 3, 6, and 12
months after the operation.
Recurrences of the arrhythmia were treated by improving the
medical treatment. Patients with AF despite optimal medical ther-
apy had at least 1 attempt of external direct-current (DC) shock.
Six months after surgery, oral anticoagulants were discontinued
in patients with stable sinus rhythm and bilateral atrial contraction,
in the absence of any other indications.
Figure 2. Epicardial beating heart ablation around the left pul-
monary veins ostia.The Journal of ThoraciConduction Block Validation
Electrical isolation of right and left pulmonary vein couples was
acutely assessed in 12 patients. Two monopolar electrodes were
attached to the intrapericardial portion of the pulmonary vein
couple (1 electrode on each vein), and DC shock was admin-
istered when needed. The pacing threshold was then assessed
before and after the encircling lesion, on cardiopulmonary
bypass.
Statistical Analysis
The following variables were analyzed for a possible correlation
with the occurrence of AF, left atrial flutter (defined as any form
of atypical flutter with isoelectric or negative P waves in aVL and
positive P waves in V1 and III), and any type of left atrial
arrhythmia (AF or left flutter) at follow-up. Preoperative variables
included age, gender, left atrial diameter, type (continuous vs
intermittent) and duration of AF, ejection fraction, systolic pulmo-
nary artery pressure, left ventricular telediastolic pressure and
volume, New York Heart Association functional class, type of
associated organic heart disease, cause of mitral disease (degen-
erative vs rheumatic), and prior heart surgery. Operative variables
included type of surgical procedure, reconstructive versus replace-
ment valve surgery, and duration of cardiopulmonary bypass and
cardiac arrest. Postoperative variables included total bleeding,
reexploration, type of antiarrhythmic prophylaxis, overall inten-
sive care unit, and hospital stay. Such variables, as assessed by the
Kolmogorov-Smirnov test, were non-normally distributed. There-
fore, values are expressed as median, 25th and 75th percentiles
(Q1;Q3) for continuous variables, and as N (%) for categoric
variables, unless stated otherwise.
The possible association between arrhythmia recurrence at each
time point and all other variables was investigated by chi-square
test and Mann-Whitney U test as appropriate. Multiple logistic
regression analysis was run including all variables that resulted in
P values less than .1 at univariate analysis. To account for multiple
Figure 3. Connecting lesion from the atriotomy to
the left upper pulmonary vein (left) and final set of
ablation lines (right).c and Cardiovascular Surgery ● Volume 130, Number 2 493
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the P value was set at .01.
Results
Operative Results, Morbidity, and Mortality
The open heart procedures are detailed in Table 2. Cardio-
pulmonary bypass time was 93 minutes (81-106 minutes).
Aortic crossclamp duration was 63 minutes (53-78 min-
utes). The time spent ablating during aortic occlusion never
exceeded 2 minutes.
No complication related to bipolar ablation was re-
corded. Four patients (4%) required reexploration for bleed-
ing. Overall, intensive care unit stay was 2 days (1-4 days)
and postoperative hospital stay was 7 days (6-12 days).
Major complications occurred in 2 patients. A 65-year-old
female patient had a type B aortic dissection with transient
lower limb ischemia, acute renal failure, and respiratory
insufficiency 12 hours after mitral and tricuspid repair,
plication of the ascending aorta, and ablation. Another 65-
year-old woman underwent emergency percutaneous trans-
luminal coronary angioplasty immediately after arrival in
the intensive care unit because of acute embolic occlusion
of the circumflex artery after mitral valve replacement,
tricuspid repair, and ablation. One 79-year-old woman died
37 days after mitral valve replacement, tricuspid repair, and
ablation because of rectus muscles hematoma leading to
acute renal failure and eventually to respiratory
insufficiency.
Follow-up was 100% complete (median 7 months; 4-9
months).
No thromboembolic event was recorded, and no patient
TABLE 2. Surgical procedures
Patients 90
Mitral repair 36 (40%)
Anuloplasty 10 (11%)
Edge to edge 15 (17%)
Quadrangular resection 11 (12%)
Mitral commissurotomy 4 (4%)
Mitral replacement 40 (44%)
Biologic 8 (9%)
Mechanical 32 (36%)
Tricuspid annuloplasty 44 (49%)
CABG 5 (6%)
Aortic valve replacement 13 (14%)
Biologic 5 (6%)
Mechanical 8 (9%)
VSD repair 1 (1%)
ASD repair 6 (7%)
Replacement of ascending aorta 2 (2%)
Two or more procedures 56 (62%)
CABG, Coronary artery bypass grafting; VSD, ventricular septal defect;
ASD, atrial septal defect.died.
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The baseline pacing threshold on 24 pulmonary vein pairs
was 3.3 mA (2.4-4 mA). After a single RF bipolar ablation
on cardiopulmonary bypass, pacing showed a complete
conduction block (no pacing at  20 mA) in 22 of 24
pulmonary vein couples (92%). In 2 right pulmonary vein
couples, the pacing threshold remained unchanged after
ablation (5 mA in 1 patient and 2 mA in 1 patient). A repeat
application led to complete block in both cases.
Rhythm
All patients were free from AF at arrival in the intensive
care unit. Thirty-nine patients (43%) experienced some
form of sustained supraventricular arrhythmia during the
hospital stay. At discharge, 53 of 89 patients (60%; 95%
confidence interval [CI]: 49%-70%) were in normal sinus
rhythm. The proportion of patients with a recovered sinus
rhythm was then 79% (95% CI: 68%-87%) at 3 months,
87% (95% CI: 75%-95%) at 6 months, and 89% (95% CI:
65%-99%) at 1-year control (Figure 4).
Overall, 38 patients (43%) underwent at least 1 DC
shock at any time after surgery. Eight patients (9%) had 2 or
more attempts.
The occurrence of AF or left flutter at 3 months was
influenced by preoperative left atrial diameter (P  .0014).
At multivariate analysis the odds ratio for each 0.5-cm
increment of left atrial diameter was 1.49 (95% CI: 1.23%-
1.81%). No other significant correlation was found. In par-
ticular, no predictor of left flutter was identified.
A permanent pacemaker was implanted in 1 patient with
preoperative sick sinus syndrome.
Two patients (2%) experienced typical counterclockwise
right atrial flutter 3 months after surgery and were successfully
treated with percutaneous ablation of the cavo-tricuspid isth-
mus. Six patients (7%) had left atrial flutter, all of them
within 3 months from mitral surgery. One patient recovered
sinus rhythm with antiarrhythmic medications, and 1 patient
required DC shock and medications. Two patients under-
went an electrophysiologic study with a transseptal ap-
proach at 3 months. Both studies showed an optimal isola-
tion of the pulmonary veins. In both cases a reentry circuit
around the mitral valve annulus was documented and inter-
rupted through a left isthmus RF ablation line. In 1 patient
a reentry circuit around a right atriotomy incision also
required ablation. Both patients recovered sinus rhythm at
the completion of the procedure, without electrical
cardioversion.
Two patients are presently waiting to be admitted for
electrophysiologic assessment.
Of 24 patients followed up for more than 6 months, 12
(50%) were not receiving drugs, 3 (12.5%) were receiving
low-dose sotalol, and 3 (12.5%) were receiving -blockers.
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amiodarone.
All transthoracic echo-Doppler controls performed 3 or
more months after surgery in patients in sinus rhythm
showed an effective contraction (A-wave  10 cm/s) of
both atria.
Discussion
The rate of sinus rhythm maintenance after concomitant
surgical treatment of AF through bipolar RF left atrial
ablation improves progressively during the first year after
surgery. At 1 year, 89% of the patients were free from AF
in our series. Our data are in line with the good early clinical
results recently reported by other groups studying intraop-
erative bipolar RF ablation.16-18 Of note, such results com-
pare favorably with the 60% to 92% success rate reported at
6 to 12 months after left atrial ablation with the diverse
unipolar devices available for clinical use.1,2,12,19
Success rates in excess of 95% have only been described
after the maze operation.20,21 But such technique has never
become popular in the context of concomitant AF ablation,
because it is technically demanding and it significantly
increases postoperative morbidity.22 Moreover, in experi-
enced hands, a concomitant maze carries a 20% or greater
risk of postoperative pacemaker implantation.21 Some of the
lines of the original maze procedure are today deemed
redundant. Cox has recently proposed performing only the
left part of the maze and a cavo-tricuspid ablation line.6
In an earlier series of patients treated with unipolar RF,
in whom the same lesion set was completed by a mitral line,
The Journal of Thoraciour 1-year success rate was 79%.12 So, despite a simplifi-
cation of the lesion set, in our hands the efficacy of bipolar
RF seems, if anything, slightly superior to that of unipolar
RF.
Data on transmurality of beating-heart epicardial abla-
tions with unipolar devices are all but satisfactory. Although
acutely effective in most cases, epicardial microwave abla-
tion on the beating heart at times fails to accomplish elec-
trical isolation even after repeat ablation.9 This is true also
for unipolar RF ablation, and it has been related by Santiago
et al13 to the composition and thickness of the atrial wall.
The major obstacle to the progression of the lesion through
the subendocardial layer is the convective cooling exerted
by blood flow through the atrial chamber.
Bipolar systems are specifically designed to work epi-
cardially. The clamping mechanism abates the endocardial
convective cooling and reduces tissue thickness by com-
pression, at the same time improving contact. Prasad and
colleagues14 demonstrated atrial ablations achieved with
bipolar RF to be predictably transmural both acutely and
after 3 months in pigs. In our series pacing threshold as-
sessment showed a complete conduction block in 92%
(22/24) of the pulmonary vein couples after a single ablation
and in 100% after 1 repeat ablation. These data are similar
to those described by Gillinov and McCarthy23 with a
similar device and confirm the efficacy of bipolar RF. In-
terestingly, the 2 ineffective encircling ablations left the
pacing threshold completely unchanged. This all-or-nothing
effect suggests a gap caused by suboptimal positioning of
Figure 4. Rhythm after surgery.
SR, Sinus rhythm; AF, atrial
fibrillation.the clamp (incomplete clamping or local folding of the atrial
c and Cardiovascular Surgery ● Volume 130, Number 2 495
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transmurality of the lesions.
On the basis of our experience, it is safe to assume that
in the absence of any validation system, epicardial isolation
of the pulmonary veins on cardiopulmonary bypass can be
predictably achieved with bipolar RF by performing 2 par-
allel ablations. This generally takes less than 2 minutes for
each pulmonary vein pair after minor dissection of the
posterior pericardial reflections.
Another important aspect of bipolar ablation is the safety
profile. Injury to the esophagus or to the bronchial tree has
been found to occur in as much as 1% of patients ablated
with unipolar RF.24 Collateral damage of the structures
surrounding the heart has not occurred in this series, and it
is actually very unlikely with bipolar ablation. In fact,
during the ablation, only the outer, inactive part of the
clamp is in contact with the parietal pericardium. Only the
tissue that is held between the jaws is heated significantly,
and thermal spread is thus minimized.
The increased swiftness and safety of the ablation pro-
cedure stimulated in our experience an expansion of the
indications in patients with a poor ventricular function and
in those requiring complex and/or multiple open heart
procedures.
As already reported after other ablation proce-
dures,1,5,7,19 the high rate of early supraventricular arrhyth-
mias (43% in this series) justifies the routine use of antiar-
rhythmic prophylaxis and a more liberal use of DC shock
during the first postoperative weeks. From 3 to 6 months
after surgery, the rhythm stabilizes, rendering withdrawal of
amiodarone possible in most patients.
A larger left atrial diameter at 3-month follow-up was a
predictor of the occurrence of relapsing AF or left atrial
flutter. One possible explanation is that a simplified left
atrial approach as the one described is less effective in
curing those “worse” cases with a larger atrium. But still,
such correlation was not a constant finding, and it needs to
be confirmed by larger series and longer follow-up. In fact,
the smaller sample size at latest controls might have pre-
vented some predictors to be significant in the present study.
The only patient requiring implantation of a permanent
pacemaker after surgery had a bradytachycardia syndrome
before surgery. This confirms our and others’ impression
that the avoidance of any right atrial ablation line renders
postoperative sinus node dysfunction a rare occur-
rence.1,5,8,9,12,19 On the other hand, a cavo-tricuspid line
would most probably have prevented the occurrence of
typical right atrial flutter, which required percutaneous ab-
lation in 2 of our patients.
More worrisome is the 7% rate of postoperative left atrial
flutter registered within the first 3 months in this series.
From a clinical standpoint, left atrial flutter is in fact prob-
ably the worst postablation arrhythmia because it is not
496 The Journal of Thoracic and Cardiovascular Surgery ● Augueasily managed by drugs, more often than not it relapses
after DC shock, and it requires complex transseptal mapping
and ablation procedures. It is noteworthy that in our prior
experience with unipolar RF the incidence of left flutter/
tachycardia was less than 1%. A possible explanation is that
the omission of the mitral line, because of the potential risk
of coronary injury during bipolar ablation in this area, has
actually left the substrate for a left isthmus reentry unad-
dressed. This hypothesis is substantiated by the finding of a
reentry circuit around the mitral valve annulus in both
patients with left atrial flutter undergoing electrophysiologic
study in this series.
The mitral line has been a cornerstone in AF surgery ever
since the original design of the maze operation25,26 and is
now also widely applied by electrophysiologists.27,28 An
incompleteness of the mitral line has been related to some
cases of failure of the ablation procedure.12,29
Despite the good sinus rhythm recovery rates we re-
corded, such a substantial incidence of postoperative atyp-
ical flutter deserves consideration. While virtually allowing
the completion of the ablation procedure epicardially on the
beating heart, the omission of the mitral line may increase
the likelihood of left flutter, turning a bad arrhythmia into a
worse one. Even if such arrhythmia can be dealt with in the
electrophysiology laboratory, at present this requires con-
siderable expertise with transseptal procedures. Therefore,
especially if a specific electrophysiologic expertise is not
available, according to our findings, omitting the mitral line
may not be the most sensible option when using bipolar RF.
Other alternative strategies should then be taken into
consideration such as the following:
● Complete the mitral line with a different unipolar device
(eg, a reusable cryoprobe when this is available) in the
coronary-free segment of the A-V groove.30
● Perform the ablation with bipolar RF or a unipolar abla-
tor after surgical dissection of the A-V junction to isolate
the coronary artery.
Unfortunately, among the available ablation systems, no
catheter is presently usable in both the bipolar and the
unipolar modes.
Conclusions
Bipolar RF ablation of the left atrium grants acute electrical
isolation. A simplified left atrial lesion set performed with
bipolar RF is highly effective in eliminating AF at 1 year
after open surgery. The safety profile and negligible addi-
tion of time required make bipolar RF a suitable option for
the concomitant treatment of AF even in the most complex
cases and in those with a poorer left ventricular function.
Our experience suggests that the addition of a lesion to
the mitral annulus is advisable to prevent left atrial
flutter.
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